[确定类风湿关节炎患者的心血管风险：首先证明干预措施的有效性]
[Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first].
作者信息
Thomas Siep
机构信息
Erasmus Medisch Centrum, afd. Huisartsgeneeskunde, Rotterdam, the Netherlands.
出版信息
Ned Tijdschr Geneeskd. 2011;155(30-31):A3563.
PMID:22085518
Abstract
In the multidisciplinary Dutch guideline on Cardiovascular Risk Management (revision 2011) the recommendation for preventive treatment of elevated risks of cardiovascular disease in patients with arthritis lacks a trial-based justification. This section should therefore be removed. Introduction of clinical guidelines with recommendations justified by evidence of an unacceptably low grade is a growing international tendency that should be stopped.
摘要
在荷兰多学科心血管风险管理指南（2011年修订版）中，针对关节炎患者心血管疾病风险升高进行预防性治疗的建议缺乏基于试验的依据。因此，这部分内容应予以删除。引入基于低质量证据的建议的临床指南这种国际趋势日益增长，应当予以制止。
相似文献
1
[Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first].
Ned Tijdschr Geneeskd. 2011;155(30-31):A3563.
2
[Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first].
Ned Tijdschr Geneeskd. 2011;155(29):A3563.
3
Cardiovascular risk estimation and management in rheumatoid arthritis: comment on the EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis.
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 87):S-16-7. Epub 2014 Oct 22.
4
Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II.
J Clin Epidemiol. 2014 Nov;67(11):1274-85. doi: 10.1016/j.jclinepi.2014.07.005. Epub 2014 Sep 16.
5
[Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)].
Ned Tijdschr Geneeskd. 2012;156(36):A5104.
6
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3.
7
Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion.
Semin Arthritis Rheum. 2014 Aug;44(1):1-8. doi: 10.1016/j.semarthrit.2014.01.002. Epub 2014 Jan 24.
8
Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators.
Arthritis Care Res (Hoboken). 2015 Feb;67(2):169-79. doi: 10.1002/acr.22419.
9
Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.
Curr Rheumatol Rep. 2017 Apr;19(4):16. doi: 10.1007/s11926-017-0643-y.
10
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
Ann Rheum Dis. 2010 Feb;69(2):325-31. doi: 10.1136/ard.2009.113696. Epub 2009 Sep 22.
Zotero 插件